Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of raltegravir (MK0518) in HIV-infected patients failing current antiretroviral therapy, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2009-09-28